Clinical Research Facility

White Marsh, Maryland

We've found

6 trials

at this facility

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

Status: Enrolling, Phase III
Updated: 12/31/1969

from

White Marsh, MD

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Status: Enrolling, Phase II
Updated: 4/24/2014

from

White Marsh, MD

Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

White Marsh, MD

Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

White Marsh, MD

Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma

Status: Enrolling, Phase III
Updated: 12/31/1969

from

White Marsh, MD

Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

White Marsh, MD

Use our guide to learn which trials are right for you!